Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTCy vs Standard Care for GVHD Prophylaxis in Acute Leukemia
NCT04314219Phase 3Recruiting
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Aug 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by King Faisal Specialist Hospital and Research Centre. Started Aug 2021; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04314219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04314219.